AdaptVac
H├╕rsholm
About AdaptVac
AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines. The goal of the Joint Venture is to create a world class unit for the development of highly competitive vaccines and therapeutics against infectious diseases, cancer, and immunological disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $12.5M
- Last round: Grant (Jun 2025)
- Website: adaptvac.com
- Phone: +45 26394649
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/adaptvac-16540 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.